News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
192,771 Results
Type
Article (10004)
Company Profile (65)
Press Release (182702)
Section
Business (58725)
Career Advice (591)
Deals (10784)
Drug Delivery (28)
Drug Development (24915)
Employer Resources (39)
FDA (5053)
Job Trends (4755)
News (98596)
Policy (7360)
Tag
2024 BioForest Digital (4)
2024 BioMidwest Digital (2)
2024 Biotech Bay Standard (5)
2024 Biotech Beach Digital (3)
2024 Biotech Beach Standard (3)
2024 Genetown Standard (3)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (2)
2025 Lone Star Bio Digital (3)
2026 Genetown Elite (1)
Academia (812)
Accelerated approval (1)
Adcomms (5)
Allergies (26)
Alliances (16216)
ALS (25)
Alzheimer's disease (352)
Antibody-drug conjugate (ADC) (46)
Approvals (5088)
Artificial intelligence (64)
Autoimmune disease (6)
Automation (6)
Bankruptcy (36)
Best Places to Work (4171)
BIOSECURE Act (3)
Biosimilars (35)
Biotechnology (48)
Bladder cancer (23)
Brain cancer (10)
Breast cancer (85)
Cancer (792)
Cardiovascular disease (54)
Career advice (508)
Career pathing (6)
CAR-T (52)
Cell therapy (168)
Cervical cancer (8)
Clinical research (20494)
Collaboration (300)
Compensation (77)
Complete response letters (4)
COVID-19 (836)
CRISPR (18)
C-suite (76)
Cystic fibrosis (37)
Data (819)
Denatured (6)
Depression (7)
Diabetes (86)
Diagnostics (2112)
Digital health (6)
Diversity (1)
Diversity, equity & inclusion (9)
Drug discovery (43)
Drug pricing (30)
Drug shortages (6)
Duchenne muscular dystrophy (27)
Earnings (23084)
Editorial (10)
Employer branding (5)
Employer resources (33)
Events (25514)
Executive appointments (245)
FDA (5454)
Featured Employer (9)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (6)
Funding (274)
Gene editing (44)
Generative AI (3)
Gene therapy (96)
GLP-1 (242)
Government (1198)
Grass and pollen (1)
Guidances (24)
Healthcare (5639)
Huntington's disease (7)
IgA nephropathy (14)
Immunology and inflammation (37)
Indications (14)
Infectious disease (878)
Inflammatory bowel disease (42)
Inflation Reduction Act (7)
Influenza (21)
Intellectual property (30)
Interviews (115)
IPO (4833)
IRA (19)
Job creations (807)
Job search strategy (430)
Kidney cancer (7)
Labor market (7)
Layoffs (98)
Leadership (6)
Legal (1100)
Liver cancer (17)
Lung cancer (121)
Lymphoma (67)
Machine learning (1)
Management (15)
Manufacturing (89)
MASH (12)
Medical device (4278)
Medtech (4279)
Mergers & acquisitions (6157)
Metabolic disorders (191)
Multiple sclerosis (35)
NASH (3)
Neurodegenerative disease (32)
Neuropsychiatric disorders (8)
Neuroscience (526)
NextGen: Class of 2025 (1949)
Non-profit (1090)
Northern California (960)
Now hiring (10)
Obesity (98)
Opinion (75)
Ovarian cancer (40)
Pain (24)
Pancreatic cancer (23)
Parkinson's disease (42)
Partnered (4)
Patents (66)
Patient recruitment (32)
Peanut (14)
People (16255)
Pharmaceutical (12)
Pharmacy benefit managers (4)
Phase I (7062)
Phase II (9269)
Phase III (6340)
Pipeline (434)
Podcasts (22)
Policy (40)
Postmarket research (549)
Preclinical (2623)
Press Release (13)
Prostate cancer (25)
Psychedelics (9)
Radiopharmaceuticals (92)
Rare diseases (126)
Real estate (1773)
Recruiting (16)
Regulatory (5659)
Reports (14)
Research institute (728)
Resumes & cover letters (68)
Rett syndrome (1)
RSV (12)
Schizophrenia (19)
Series A (64)
Series B (28)
Service/supplier (6)
Sickle cell disease (20)
Southern California (773)
Special edition (3)
Spinal muscular atrophy (51)
Sponsored (9)
Startups (1282)
State (1)
Stomach cancer (6)
Supply chain (24)
Tariffs (6)
The Weekly (16)
United States (6968)
Vaccines (182)
Venture capitalists (16)
Webinars (6)
Weight loss (72)
Women's health (7)
Worklife (5)
Date
Today (19)
Last 7 days (233)
Last 30 days (889)
Last 365 days (11394)
2025 (2793)
2024 (11884)
2023 (13252)
2022 (16691)
2021 (18203)
2020 (17285)
2019 (14062)
2018 (10808)
2017 (10304)
2016 (9186)
2015 (10732)
2014 (7344)
2013 (6156)
2012 (6859)
2011 (6962)
2010 (5758)
Location
Africa (206)
Alabama (13)
Alaska (3)
Arizona (39)
Arkansas (4)
Asia (11234)
Australia (2292)
California (2088)
Canada (586)
China (168)
Colorado (124)
Connecticut (72)
Delaware (54)
Europe (28433)
Florida (223)
Georgia (56)
Idaho (18)
Illinois (154)
India (7)
Indiana (100)
Iowa (2)
Japan (51)
Kansas (36)
Kentucky (1)
Louisiana (2)
Maine (14)
Maryland (225)
Massachusetts (1391)
Michigan (56)
Minnesota (73)
Mississippi (1)
Missouri (17)
Montana (9)
Nebraska (4)
Nevada (9)
New Hampshire (23)
New Jersey (540)
New Mexico (8)
New York (511)
North Carolina (299)
North Dakota (2)
Northern California (960)
Ohio (74)
Oklahoma (5)
Oregon (12)
Pennsylvania (371)
Puerto Rico (2)
Rhode Island (11)
South America (322)
South Carolina (5)
Southern California (773)
Tennessee (40)
Texas (246)
Utah (25)
Virginia (29)
Washington D.C. (10)
Washington State (157)
West Virginia (1)
Wisconsin (23)
192,771 Results for "front range biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
FDA
FDA Job Cuts, Key Departures Bring ‘Revolving Door’ Debate Front and Center
With the recently announced layoffs of 3,500 FDA staffers and exits of branch directors Patrizia Cavazzoni and Peter Marks, there could be a wealth of talent available to biopharma companies. Does this pose an ethical quandary? It depends on who you ask.
April 2, 2025
·
6 min read
·
Heather McKenzie
Press Releases
BRTX-100 Front and Center at ORS 2025
February 11, 2025
·
7 min read
Press Releases
4DMT Announces First Patients Enrolled in 4FRONT-1 Phase 3 Clinical Trial Evaluating 4D-150 in Wet AMD
March 10, 2025
·
6 min read
Press Releases
Enveric Biosciences Announces Broad Range of Patent Issuances
November 5, 2024
·
5 min read
Leadership
Leading From the Front: 3 Leadership Lessons From Mark Cuban
Businessman and entrepreneur Mark Cuban recently discussed leadership with Leadership Lab columnist Michael Pietrack. The three lessons that came out of that conversation start with one word: caring.
December 17, 2024
·
6 min read
·
Michael Pietrack
Press Releases
4DMT Presents Positive 52-Week Results from Phase 2b Cohort of PRISM Wet AMD Study and Long-term Durability Data Supporting 4D-150 4FRONT Global Registration Program
February 9, 2025
·
9 min read
Deals
Wedgewood Pharmacy Acquires Front Range Laboratories, Addressing a Growing Need for Testing Compounded Medications for Animal Health
Wedgewood Pharmacy has acquired Front Range Laboratories in Loveland, CO, which is a full-service testing laboratory that has been a trusted partner of compounding pharmacies for more than 25 years.
February 27, 2023
·
2 min read
C-suite
Biotech a Bright Spot for Female Founders Amid DEI Pullback
A new Pitchbook report found $4.3 billion in funding to women-fronted biotech companies across 121 deals. The increase comes as sociopolitical headwinds slam into initiatives to support women and minorities.
March 6, 2025
·
2 min read
·
Annalee Armstrong
Press Releases
Lucid Diagnostics Signs Memorandum of Understanding with Front Line Mobile Health
September 3, 2024
·
4 min read
Deals
Coherus BioSciences Announces Divestiture of YUSIMRY (adalimumab-aqvh) in a $40 Million Upfront All Cash Transaction– Transaction aligns with Coherus’ strategic focus on oncology –
Coherus BioSciences, Inc today announced it agreed to divest YUSIMRY (adalimumab-aqvh) to Hong Kong King-Friend Industrial Co. Ltd. (HKF) for up-front all-cash consideration of $40 million.
June 27, 2024
·
4 min read
1 of 19,278
Next
